Skip to content

Second generation NNRTIs poised for treatment-naïve studies

Starting treatment at higher CD4 cell counts reduces risk of peripheral neuropathy, anaemia and kidney disease

AZT, 3TC and efavirenz: a tolerable first-line regimen for South African men

More evidence from UK of improvements in prognosis since advent of HAART, but concern over late diagnosis

Start treatment when CD4 cell count is 350, say revised US guidelines

Starting antiretroviral therapy early at higher CD4 cell counts improves short term treatment outcomes in resource-poor countries

Experts endorse European plan to reduce late HIV diagnosis

Abacavir hypersensitivity screening not a substitute for 'clinical vigilance' say investigators at UK's largest HIV clinic

Low CD4 cell count, big drop in viral load, and boosted PI are risk factors for IRIS